P927: ACTUAL USAGE OF CURRENT SYSTEMIC TREATMENTS AND INFLUENCE OF KEY DRIVERS FOR MULTIPLE MYELOMA IN THE FIRST 2 LINES OF THERAPY. DATA FROM REAL-WORLD STUDY IN EU5 COUNTRIES.

Detalles Bibliográficos
Autores principales: Blin, Nicolas, Ertl, Siegfried, Schneider, Elodie, Mai, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431017/
http://dx.doi.org/10.1097/01.HS9.0000970612.94379.d8
_version_ 1785091099020230656
author Blin, Nicolas
Ertl, Siegfried
Schneider, Elodie
Mai, Christine
author_facet Blin, Nicolas
Ertl, Siegfried
Schneider, Elodie
Mai, Christine
author_sort Blin, Nicolas
collection PubMed
description
format Online
Article
Text
id pubmed-10431017
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104310172023-08-17 P927: ACTUAL USAGE OF CURRENT SYSTEMIC TREATMENTS AND INFLUENCE OF KEY DRIVERS FOR MULTIPLE MYELOMA IN THE FIRST 2 LINES OF THERAPY. DATA FROM REAL-WORLD STUDY IN EU5 COUNTRIES. Blin, Nicolas Ertl, Siegfried Schneider, Elodie Mai, Christine Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431017/ http://dx.doi.org/10.1097/01.HS9.0000970612.94379.d8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Blin, Nicolas
Ertl, Siegfried
Schneider, Elodie
Mai, Christine
P927: ACTUAL USAGE OF CURRENT SYSTEMIC TREATMENTS AND INFLUENCE OF KEY DRIVERS FOR MULTIPLE MYELOMA IN THE FIRST 2 LINES OF THERAPY. DATA FROM REAL-WORLD STUDY IN EU5 COUNTRIES.
title P927: ACTUAL USAGE OF CURRENT SYSTEMIC TREATMENTS AND INFLUENCE OF KEY DRIVERS FOR MULTIPLE MYELOMA IN THE FIRST 2 LINES OF THERAPY. DATA FROM REAL-WORLD STUDY IN EU5 COUNTRIES.
title_full P927: ACTUAL USAGE OF CURRENT SYSTEMIC TREATMENTS AND INFLUENCE OF KEY DRIVERS FOR MULTIPLE MYELOMA IN THE FIRST 2 LINES OF THERAPY. DATA FROM REAL-WORLD STUDY IN EU5 COUNTRIES.
title_fullStr P927: ACTUAL USAGE OF CURRENT SYSTEMIC TREATMENTS AND INFLUENCE OF KEY DRIVERS FOR MULTIPLE MYELOMA IN THE FIRST 2 LINES OF THERAPY. DATA FROM REAL-WORLD STUDY IN EU5 COUNTRIES.
title_full_unstemmed P927: ACTUAL USAGE OF CURRENT SYSTEMIC TREATMENTS AND INFLUENCE OF KEY DRIVERS FOR MULTIPLE MYELOMA IN THE FIRST 2 LINES OF THERAPY. DATA FROM REAL-WORLD STUDY IN EU5 COUNTRIES.
title_short P927: ACTUAL USAGE OF CURRENT SYSTEMIC TREATMENTS AND INFLUENCE OF KEY DRIVERS FOR MULTIPLE MYELOMA IN THE FIRST 2 LINES OF THERAPY. DATA FROM REAL-WORLD STUDY IN EU5 COUNTRIES.
title_sort p927: actual usage of current systemic treatments and influence of key drivers for multiple myeloma in the first 2 lines of therapy. data from real-world study in eu5 countries.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431017/
http://dx.doi.org/10.1097/01.HS9.0000970612.94379.d8
work_keys_str_mv AT blinnicolas p927actualusageofcurrentsystemictreatmentsandinfluenceofkeydriversformultiplemyelomainthefirst2linesoftherapydatafromrealworldstudyineu5countries
AT ertlsiegfried p927actualusageofcurrentsystemictreatmentsandinfluenceofkeydriversformultiplemyelomainthefirst2linesoftherapydatafromrealworldstudyineu5countries
AT schneiderelodie p927actualusageofcurrentsystemictreatmentsandinfluenceofkeydriversformultiplemyelomainthefirst2linesoftherapydatafromrealworldstudyineu5countries
AT maichristine p927actualusageofcurrentsystemictreatmentsandinfluenceofkeydriversformultiplemyelomainthefirst2linesoftherapydatafromrealworldstudyineu5countries

Ejemplares similares